4 completed, 1 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
By phase and status
Follow Faropenem: new trials by email Literature Review of Faropenem trials Research Report on Faropenem
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP) Faropenem, Co-amoxiclav, Clarithromycin 500 mg - Pneumonia, Community-Acquired, Bacterial Pneumonia | Phase 4 | Completed | Dr. Md. Alimur Reza | 129 | 2025-02-20 | 2026-08-04 |
Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers Faropenem, Amoxicillin/clavulanic acid, Cefadroxil - Pulmonary Tuberculosis | Phase 2 | Completed | National University Hospital, Singapore | 58 | 2019-02-11 | 2020-03-23 |
Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers Faropenem, Amoxicillin/clavulanic acid 500mg/125mg, Rifampicin - Tuberculosis | Phase 1 | Completed | National University Hospital, Singapore | 43 | 2015-02-01 | 2017-04-05 |
Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis Meropenem, Faropenem, Amoxycillin/clavulanic acid - Pulmonary Tuberculosis | Phase 2 | Completed | TASK Applied Science | 46 | 2014-09-01 | 2018-09-13 |
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia Faropenem, Ertapenem - Community Acquired Pneumonia | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 540 | 2013-10-01 | 2013-09-10 |
Conditions studied
Community-Acquired Pneumonia (2) · Tuberculosis, Pulmonary (2) · Pneumonia, Bacterial (1) · Tuberculosis (1)
Sponsors
National University Hospital, Singapore (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Dr. Md. Alimur Reza (1) · TASK Applied Science (1)
Countries
Singapore (2) · Bangladesh (1) · China (1) · Philippines (1) · South Africa (1) · Uganda (1)
Top investigators
Nicholas Paton (2) · Prof. Khan Abul Kalam Azad (1) · Prof. Quazi Tarikul Islam, MBBS, FCPS, FACP (USA), FRCP, (1)
Results publications
PMID 28333342